2014年8月8日金曜日

Micro-Tublle Stabilizing Alkaloids CERATAMINE Congeners

Summary;

Sequential metalation onto the  tribromoimidazole followed by  functionalization led to the efficiently generate a key imidazole intermediate containing the vinyl bromide and the amide functionalities, thar are keys to the success to the total synthesis described herein.

Abstract

Abstract Image
 
Two synthetic approaches to the microtubule-stabilizing ceratamine alkaloids are described. The first approach involved attempts to graft an aminoimidazole moiety onto an azepine ring to form partially hydrogenated versions of the unprecedented aromatic imidazo[4,5-d]azepine core of the ceratamines.
 
 
This route ultimately failed because it was not possible to aromatize the partially hydrogenated ceratamine intermediates.
 
 
A second approach started with tribromoimidazole that was sequentially metalated and functionalized to efficiently generate a key imidazole intermediate containing vinyl bromide and amide functionalities.
 
 
An intramolecular Buchwald vinyl amidation reaction converted this key intermediate into a bicyclic imidazo[4,5-d]azepine that was at the same oxidation state as the aromatic core of the ceratamines.
 
 
The 2-amino functionality present on the imidazole ring of the ceratamines was installed using a Buchwald/Hartwig amination reaction on a 2-chloroimidazole precursor.
 
 
Deprotection and aromatization resulted in the first synthesis of desbromoceratamine A (55) and desmethyldesbromoceratamine A (60).
 
 
An unanticipated addition of atmospheric oxygen was encountered during deprotection of the imidazole ring in the last step of the synthesis leading to C-11 oxygenated ceratamine analogues as byproducts.
 
 
Evaluation of the synthetic ceratamines in a TG3 cell-based assay for mitotic arrest revealed that the C-14 and C-16 bromine substituents in ceratamine A (1) play a major role in the antimitotic potency of the natural product.
 
 
The synthetic route to ceratamine analogues has provided sufficient quantities of desbromoceratamine A (55) for testing in mouse models of cancer.
 
 
 

Citing Articles

View all 7 citing articles
Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
This article has been cited by 7 ACS Journal articles (5 most recent appear below).

0 件のコメント:

コメントを投稿